Xtant Reports 3Q18 Revenue of $17.3MM, -12.7% vs. 3Q17

Xtant Medical reported 3Q18 revenue of $17.3MM, -12.7% vs. 3Q17. While leadership was encouraged by profitability improvements from facility consolidations, sales results remain below expectations. Revenue has fallen mostly due to a company-initiated termination of distributor agreements, as well as challenges in sales channel management.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us